Hypertension and risk of brain metastasis from small cell lung cancer

A retrospective follow-up study

Abe E. Sahmoun, L. Douglas Case, Sudhir Chavour, Sohail Kareem, Gary Schwartz

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Although metastatic brain cancer is one of the most common forms of cancer, little is known about the factors associated with its development. We examined the hypothesis that hypertension may increase the risk for brain metastasis (BM) in patients with primary small cell lung cancer (SCLC). Materials and Methods: A retrospective review of medical charts of patients diagnosed with SCLC between June, 1986 and June, 2003 at MeritCare in Fargo, ND, USA, was done to determine which of these patients subsequently developed brain metastases. The effects of hypertension, age, gender, body mass index and the site of SCLC on the risk of developing BM were examined using both univariate and multivariable Cox proportional-hazards regression models. Two-way interactions between hypertension and other covariates were also included in the analyses. Results: Two hundred and thirty-two patients were identified with SCLC and 185 patients were eligible for this study. Eighty-five (45.9%) patients developed BM. Over 54% of SCLC occurred in the right lobe and more than 70% of the patients with BM had them in multiple locations. The risk of BM is significantly higher in younger patients (p-value < 0.03). Univariate analysis showed a hazard ratio (HR) for hypertension of 1.01 (95% Confidence Interval (CI) 0.6-1.6) for BM from SCLC. The multivariable Cox model showed an adjusted HR for hypertension of 1.06 (95%CI 0.7-1.6) for BM from SCLC. Conclusion: As has been consistently observed for other lung cancers, SCLC is more common in the right lung. The higher incidence of BM in younger patients suggests that more aggressive therapy is needed in these patients. Hypertension does not appear to increase the risk of BM from SCLC.

Original languageEnglish (US)
Pages (from-to)3115-3120
Number of pages6
JournalAnticancer Research
Volume24
Issue number5 B
StatePublished - Sep 1 2004

Fingerprint

Small Cell Lung Carcinoma
Neoplasm Metastasis
Hypertension
Brain
Proportional Hazards Models
Confidence Intervals
Brain Neoplasms
Lung Neoplasms
Body Mass Index
Lung
Incidence

Keywords

  • Brain
  • Hypertension
  • Metastasis
  • Small cell lung cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hypertension and risk of brain metastasis from small cell lung cancer : A retrospective follow-up study. / Sahmoun, Abe E.; Case, L. Douglas; Chavour, Sudhir; Kareem, Sohail; Schwartz, Gary.

In: Anticancer Research, Vol. 24, No. 5 B, 01.09.2004, p. 3115-3120.

Research output: Contribution to journalArticle

Sahmoun, Abe E. ; Case, L. Douglas ; Chavour, Sudhir ; Kareem, Sohail ; Schwartz, Gary. / Hypertension and risk of brain metastasis from small cell lung cancer : A retrospective follow-up study. In: Anticancer Research. 2004 ; Vol. 24, No. 5 B. pp. 3115-3120.
@article{cad8f95f879543cd861937e5312f1123,
title = "Hypertension and risk of brain metastasis from small cell lung cancer: A retrospective follow-up study",
abstract = "Background: Although metastatic brain cancer is one of the most common forms of cancer, little is known about the factors associated with its development. We examined the hypothesis that hypertension may increase the risk for brain metastasis (BM) in patients with primary small cell lung cancer (SCLC). Materials and Methods: A retrospective review of medical charts of patients diagnosed with SCLC between June, 1986 and June, 2003 at MeritCare in Fargo, ND, USA, was done to determine which of these patients subsequently developed brain metastases. The effects of hypertension, age, gender, body mass index and the site of SCLC on the risk of developing BM were examined using both univariate and multivariable Cox proportional-hazards regression models. Two-way interactions between hypertension and other covariates were also included in the analyses. Results: Two hundred and thirty-two patients were identified with SCLC and 185 patients were eligible for this study. Eighty-five (45.9{\%}) patients developed BM. Over 54{\%} of SCLC occurred in the right lobe and more than 70{\%} of the patients with BM had them in multiple locations. The risk of BM is significantly higher in younger patients (p-value < 0.03). Univariate analysis showed a hazard ratio (HR) for hypertension of 1.01 (95{\%} Confidence Interval (CI) 0.6-1.6) for BM from SCLC. The multivariable Cox model showed an adjusted HR for hypertension of 1.06 (95{\%}CI 0.7-1.6) for BM from SCLC. Conclusion: As has been consistently observed for other lung cancers, SCLC is more common in the right lung. The higher incidence of BM in younger patients suggests that more aggressive therapy is needed in these patients. Hypertension does not appear to increase the risk of BM from SCLC.",
keywords = "Brain, Hypertension, Metastasis, Small cell lung cancer",
author = "Sahmoun, {Abe E.} and Case, {L. Douglas} and Sudhir Chavour and Sohail Kareem and Gary Schwartz",
year = "2004",
month = "9",
day = "1",
language = "English (US)",
volume = "24",
pages = "3115--3120",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5 B",

}

TY - JOUR

T1 - Hypertension and risk of brain metastasis from small cell lung cancer

T2 - A retrospective follow-up study

AU - Sahmoun, Abe E.

AU - Case, L. Douglas

AU - Chavour, Sudhir

AU - Kareem, Sohail

AU - Schwartz, Gary

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Background: Although metastatic brain cancer is one of the most common forms of cancer, little is known about the factors associated with its development. We examined the hypothesis that hypertension may increase the risk for brain metastasis (BM) in patients with primary small cell lung cancer (SCLC). Materials and Methods: A retrospective review of medical charts of patients diagnosed with SCLC between June, 1986 and June, 2003 at MeritCare in Fargo, ND, USA, was done to determine which of these patients subsequently developed brain metastases. The effects of hypertension, age, gender, body mass index and the site of SCLC on the risk of developing BM were examined using both univariate and multivariable Cox proportional-hazards regression models. Two-way interactions between hypertension and other covariates were also included in the analyses. Results: Two hundred and thirty-two patients were identified with SCLC and 185 patients were eligible for this study. Eighty-five (45.9%) patients developed BM. Over 54% of SCLC occurred in the right lobe and more than 70% of the patients with BM had them in multiple locations. The risk of BM is significantly higher in younger patients (p-value < 0.03). Univariate analysis showed a hazard ratio (HR) for hypertension of 1.01 (95% Confidence Interval (CI) 0.6-1.6) for BM from SCLC. The multivariable Cox model showed an adjusted HR for hypertension of 1.06 (95%CI 0.7-1.6) for BM from SCLC. Conclusion: As has been consistently observed for other lung cancers, SCLC is more common in the right lung. The higher incidence of BM in younger patients suggests that more aggressive therapy is needed in these patients. Hypertension does not appear to increase the risk of BM from SCLC.

AB - Background: Although metastatic brain cancer is one of the most common forms of cancer, little is known about the factors associated with its development. We examined the hypothesis that hypertension may increase the risk for brain metastasis (BM) in patients with primary small cell lung cancer (SCLC). Materials and Methods: A retrospective review of medical charts of patients diagnosed with SCLC between June, 1986 and June, 2003 at MeritCare in Fargo, ND, USA, was done to determine which of these patients subsequently developed brain metastases. The effects of hypertension, age, gender, body mass index and the site of SCLC on the risk of developing BM were examined using both univariate and multivariable Cox proportional-hazards regression models. Two-way interactions between hypertension and other covariates were also included in the analyses. Results: Two hundred and thirty-two patients were identified with SCLC and 185 patients were eligible for this study. Eighty-five (45.9%) patients developed BM. Over 54% of SCLC occurred in the right lobe and more than 70% of the patients with BM had them in multiple locations. The risk of BM is significantly higher in younger patients (p-value < 0.03). Univariate analysis showed a hazard ratio (HR) for hypertension of 1.01 (95% Confidence Interval (CI) 0.6-1.6) for BM from SCLC. The multivariable Cox model showed an adjusted HR for hypertension of 1.06 (95%CI 0.7-1.6) for BM from SCLC. Conclusion: As has been consistently observed for other lung cancers, SCLC is more common in the right lung. The higher incidence of BM in younger patients suggests that more aggressive therapy is needed in these patients. Hypertension does not appear to increase the risk of BM from SCLC.

KW - Brain

KW - Hypertension

KW - Metastasis

KW - Small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=6344285571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6344285571&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 3115

EP - 3120

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5 B

ER -